UNICHEM LABORATORIES
Back to Income Statement
|
UNICHEM LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,111 Cr | ₹1,785 Cr | ₹134,302 Cr | ₹1,270 Cr | ₹1,235 Cr |
What is the latest Revenue of UNICHEM LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹2,111 Cr |
| Mar2025 | ₹1,785 Cr |
| Mar2024 | ₹134,302 Cr |
| Mar2023 | ₹1,270 Cr |
| Mar2022 | ₹1,235 Cr |
How is Revenue of UNICHEM LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,111 Cr | 18.25 | |
| Mar2025 | ₹1,785 Cr | -98.67 | |
| Mar2024 | ₹134,302 Cr | 10,476.38 | |
| Mar2023 | ₹1,270 Cr | 2.81 | |
| Mar2022 | ₹1,235 Cr | - | |
Compare Revenue of peers of UNICHEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| UNICHEM LABORATORIES | ₹3,929.0 Cr | 3.8% | 11.7% | 9.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,791.0 Cr | 1.7% | -1.4% | 21.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,081.0 Cr | 2% | 10.3% | 49.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,351.0 Cr | -0.4% | -0.5% | 38.6% | Stock Analytics | |
| CIPLA | ₹114,163.0 Cr | -0.5% | -2.5% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.3 Cr | -1.2% | 0% | -7.1% | Stock Analytics | |
UNICHEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| UNICHEM LABORATORIES | 3.8% |
11.7% |
9.8% |
| SENSEX | -1.2% |
-2.6% |
-5.2% |
You may also like the below Video Courses